Publications

Autism

Theoharides drug interactions

Theoharides Autism, basis NeuroProtek in Autism Science Digest 2010

Autism drug interactions

Autism mast cells - BBA 2012

Autism serum IL-6, TNF, luteolin - Transl Psych 9-2015

Autism subtype brain allergy - Clin Therapeutics May 2013

Autism, brain inflammation - J Neuroinflammation 2012

Autism, high serum CRH, neurotensin, dog model - Transl Psych 2104

Autism, hippocampus, molecular profiling - medRxiv Oct 2022

Autism, mastocytosis - Intl J Immunopathol Pharmacol 2009

Autism, NeuroProtek - Clin Therapeutics May 2013

Autism, NeuroProtek - IJIP6 2012

Autism, Perinatal stress - BMC Peds 9-2012

Autism, serum NT

Mast cells, IL-37 - Intl J Mol Sci 2019

Molecular Profiling of the Hippocampus of Children with Autism Spectrum Disorder - Abstract - Europe PMC

Neuroinflammation, seizures, autism - J Neuroinflamm 2011

Neurotensin, autism - PNAS 2016

Perinatal mast cells, coronavirus, autism - J Pers Med 2021

Extracellular vesicles are increased in the serum of children with autism spectrum disorder

Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders

Extracellular Mitochondrial ATP, Suramin, and Autism?

Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6

Exosomes in Neurologic and Psychiatric Disorders

Potential Etiologic Factors of Microbiome Disruption in Autism

Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism

Mold and Immunity

Effects of Mycotoxinson Neuropsychiatric Symptoms and Immune Processes

Dysregulated brain immunity and neurotrophin signaling in Rett syndrome and autism spectrum disorders

Autism Drugs in Wealthy Nations

Elevated serum neurotensin and CRH levels in children with autistic spectrum disorders...

Extracellular Mitochondrial Components Secreted from Activated Live Mast Cells Act as “Innate Pathogens” and Contribute to Autism Pathogenesis

The “missing link” in autoimmunity and autism: Extracellular mitochondrial components secreted from activated live mast cells

Focal Brain Inflammation and Autism

NeuroProtek - 2012

Autism, Seizures, JNI 2012

Autism, Allergies JADD

Novel therapeutic targets for autism

Mast cells as targets of corticotropin releasing factor and related peptides

Critical role of mast cells in inflammatory diseases and the effect of acute stress

Autism: an emerging ‘neuroimmune disorder’ in search of therapy

Autism Spectrum Disorders and Mastocytosis

Mercury induces inflammatory mediator release from human mast cells

Mitochondrial DNA and anti-mitochondrial antibodies in serum of autistic children

Neurotensin is increased in serum of young children with autistic disorder

Autism, elevated serum CRH, NT-Transl Psych 2014

Autism, NeuroProtek Clin Therapeutics May 2013

Autism, NeuroProtek, IJIP6-2012

Mast cells, stress, fear, autism, Intl J Mol Sci 2019

Theoharides Autism, basis NeuroProtek in Autism Science Digest 2010

Atopic conditions, Clin Therapeutics May 2013

Autism subtype brain allergy Clin Therapeutics May 2013

Autism, allergies, JADD 2011

Autism Diagnosis & Treatment

Children with Autism Spectrum Disorders

Flavonoids Luteolin

New Evidence indicates that the flavonoid luteolin is a better inhibitor of mast cells than the drug cromolyn

Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus

Luteolin Isolated from Juncus acutus L., a Potential Remedy for Human Coronavirus 229E

Luteolin is a potential inhibitor of COVID-19: An in silico analysis

Covid-19, Mast Cells, Lueolin Highlights

Luteolin - Neurotrauma 2020

Mast Cell Activation Beyond Histamine And Tryptase - exp Rev Clin Immunol 2023

Mast Cells, Microglia - neuro-covid cells 2023

Sars-CoC-2 Spike Protein Mast Cells - ijms, 2023

Sars-CoV-2 Spike Protein, Microglia - mol Neurobiol 2023

Sars‐CoV‐2 Spike Protein And Paf - biofactors 2022

Spike Protein, Mast Cell, Microgia, Neuro-covid cells 2023

Spike, Coronavirus, Long-covid - mol Neurobiol-nature 2002

Covid Treatment, Mast Cells - intl J Inf Dis 2022

Kempuraj - luteolin 2020

Luteolin supplements- All that glitters is not gold - Biofactors 2020

Luteolin - Neuropsychiatric Disorders

Luteolin, COVID-19, mast cells, cytokines - BioFactors 2020

Luteolin, Long-COVID brain fog - Biofactors 2021

Luteolin, MS - J Neuroinflamm 2009

Luteolin, Post-Lyme - 2016

Methlut lotion - Intl J Immunpath Pharm 2017

Methoxyluteolin, mast cells - JACI 2015

Methoxyluteolin, mast cells - mTOR, JPET 2017

Autism, elevated serum CRH, NT-Transl Psych 2014

Autism, NeuroProtek Clin Therapeutics May 2013

Autism, NeuroProtek, IJIP6-2012

Mast cells, stress, fear, autism, Intl J Mol Sci 2019

Theoharides Autism, basis NeuroProtek in Autism Science Digest 2010

CFS , flavones J Neuroinflamm 2014

Mast cells, COVID-19_Annals Allergy Asthma 2021

Mast Cells

Luteolin-rich fraction from Perilla frutescens seed meal inhibits spike glycoprotein S1 of SARS-CoV-2-induced NLRP3 inflammasome lung cell inflammation via regulation of JAK1/STAT3 pathway

Luteolin Is More Potent than Cromolyn in Their Ability to Inhibit Mediator Release from Cultured Human Mast Cells

Luteolin is a potential inhibitor of COVID-19

Podcast: Mast Cell Matters: Deep dives on MCAS

Mast Cell Over-Activation, and How it Affects our Mind and Body Well-Being
 (Passcode: q*bwPX3M)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Mast cells, Pancreatitis_2014

Mast cell activation and microbiome

Mast cell activation beyond histamine and tryptase Exp-Rev-Clin-Immunol_2023

Mast cell activation disorders, Exp Rev Clin Immunol 2014

Mast cell mediator disorder, Exp Rev Clin Imminol 2019

Mast cell, obesity asthma, Allergy 2014

Mast cells and COVID-19_medRxiv_2022

Mast cells and SARS-CoV-2_NEJM, 2023

• Mast cells in allergy inflamm Curr Pharm Des 2012

Mast cells brain inflammation and autism Eur J Pharmacol 2016

Mast cells, COVID-19_Annals Allergy Asthma 2021

Mast cells, dendritic cells_JACI 2021

Mast cells, fear, autism, Intl J Mol Sci 2019

Mast cells, FMS, pain, Front Cell Neurosci 2019

Mast cells, IBS, Dig Dis Sc 2014

Mast cells, IL-1 beta, PNAS 9-2018

• Mast cells, IL-37, Intl J Mol Sci, 2019

Mast cells, Immunity_IJMS 2023

Mast cells, inflammation, BBA 2012

Mast cells, mastocytosis and supplemental, NEJM July 9, 2015

Mast cells, meningiomas_J Neuroinflam, 2015

Mast cells, migraines_Brain Res Rev, 2005

Mast cells, MS, strress, Autoimm Rev, 2013

Mast cells, neuroinflammation_Front Cell Neurosc, 2019

Mast cells, neuron contacts, Clin Ther 2016 main

Mast cells, obesity, MI, Trends Pharm Sc 2011

Mast cells, pancreatic cancer_NEJM, 2008

Mast cells, stress, asthma Ann Allergy Asthma Immunol 2012

Mast cells, stress, fear, autism, Intl J Mol Sci 2019

Mast cells, stress, heart, Ann Allergy Asthma Immunol 2014

Mastocytose - fatigue

Mastocytosis, cognitive impairment 2012

LEGAL DISCLAIMER:

The contents of this website and any provided materials, research, or communications are for educational and informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.